Thus, we tested this possibility in 15 of the MM samples that had shown strong (3+) MET overexpression by IHC without corresponding MET-GCNG/GA and in 5 samples with 3+ expression associated with MET-GCNG/GA (3 with intermediate-level and 2 with low-level, all EMMs). This evidence concerns the gene MET and Miyoshi myopathy.